Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

12112studies shown

Showing 3,493-3,504 of 12,112

Other study type icon

RecruitingISRCTN61621571

Sustaining Positive Engagement and Recovery (SUPEREDEN) - Improving social recovery in young people with emerging severe social disability

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.

In United Kingdom

SchizophreniaOther

Countries: United Kingdom
Sponsor: Birmingham and Solihull Mental Health NHS Foundation Trust (UK)
Condition: Schizophrenia

Drug study icon

RecruitingNCT06679062

Suvorexant for Treatment of AUD and PTSD

This study is recruiting. It focuses on PTSD and currently lists participation information in the United States.

Multiple locations, including Los Angeles

PTSD, AddictionDrugFrom 21 Years to 65 Years

Countries: United States
Sponsor: Pharmacotherapies for Alcohol and Substance Use Disorders Alliance
Condition: PTSD, Addiction

Behavioral study icon

RecruitingNCT03642028

Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress

This study is recruiting. It focuses on PTSD and currently lists participation information in the United States.

Multiple locations, including Long Beach

PTSDBehavioralFrom 18 Years to 75 Years

Countries: United States
Sponsor: VA Office of Research and Development
Condition: PTSD

Other study type icon

RecruitingNCT03995121

SV2 PET Imaging With [11C]APP311

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.

In New Haven

Schizophrenia, AddictionOtherFrom 18 Years to 85 Years

Countries: United States
Sponsor: Yale University
Condition: Schizophrenia, Addiction

Other study type icon

RecruitingISRCTN47820795

Swedish unaccompanied youth refugee study

This study is recruiting. It focuses on PTSD and currently lists participation information in Sweden.

In Sweden

PTSDOther

Countries: Sweden
Sponsor: Uppsala University
Condition: PTSD

Other study type icon

RecruitingNCT02639702

Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia

This study is recruiting. It focuses on schizophrenia and currently lists participation information in Canada.

In Toronto

SchizophreniaOtherOver 18 Years

Countries: Canada
Sponsor: Centre for Addiction and Mental Health
Condition: Schizophrenia

Behavioral study icon

RecruitingNCT01627301

Sympathetic Overactivity in PTSD

This study is recruiting. It focuses on PTSD and currently lists participation information in the United States.

In Decatur

PTSDBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: Emory University
Condition: PTSD

Other study type icon

RecruitingNCT06698588

Symptom-specific Effects of Omega-3 Across Neurodevelopmental Symptoms

This study is recruiting. It focuses on ADHD and currently lists participation information in the United Kingdom.

In Swansea

ADHDOtherFrom 5 Years to 12 Years

Countries: United Kingdom
Sponsor: Swansea University
Condition: ADHD

Device study icon

RecruitingNCT07560878

Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

In Belmont

DepressionOtherOver 18 Years

Countries: United States
Sponsor: Mclean Hospital
Condition: Depression

Drug study icon

RecruitingNCT04226898

Synbiotic Compound to Reduce Symptoms of Schizophrenia

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.

In Batlimore

SchizophreniaOtherFrom 18 Years to 65 Years

Countries: United States
Sponsor: Sheppard Pratt Health System
Condition: Schizophrenia

Other study type icon

RecruitingNCT06560957

SYNCED - SYNChronized Eating in Depression in bipolarity Study

This study is recruiting. It focuses on bipolarity and currently lists participation information in Canada.

In Ottawa

Bipolarity, DepressionOtherFrom 18 Years to 55 Years

Countries: Canada
Sponsor: University of Ottawa
Condition: Bipolarity, Depression

Other study type icon

RecruitingNCT07058389

Synergy Between Physical Activity and Outdoor Green Environments to Reduce the Intensity of Negative Symptoms in Schizophrenia.

This study is recruiting. It focuses on schizophrenia and currently lists participation information in France.

In Saint-Etienne

SchizophreniaOtherFrom 18 Years to 55 Years

Countries: France
Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.